Cystic fibrosis in the year 2020: A disease with a new face
- PMID: 31899933
- DOI: 10.1111/apa.15155
Cystic fibrosis in the year 2020: A disease with a new face
Abstract
The autosomal recessive disease cystic fibrosis (CF) was once untreatable and deadly in childhood, but now most patients survive to adulthood. Many countries have instituted CF newborn screening because early diagnosis improves outcome. CF research has greatly intensified following the discovery of the CF transmembrane conductance regulator (CFTR) gene, which has more than 2000 different mutations. For patients with common mutations like F508del, CFTR modulators are life transforming and may even prevent major complications if started early in childhood. For some patients with rare CFTR mutations, a treatment path still needs to be developed. Conclusion: This review provides a general update on CF, including screening and current and future treatment.
Keywords: cystic fibrosis; diagnosis; early screening; genetic mutations; survival rates.
© 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Mehta G, Macek M, Mehta A, European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros. 2010;9:S5-21.
-
- De Boeck K, Vermeulen F, Dupont L. The diagnosis of cystic fibrosis. Presse Med. 2017;46:e97-108.
-
- Goetz D, Ren CL. Review of cystic fibrosis. Pediatr Ann. 2019;48:e154-e161.
-
- ECFS patient registry annual data report [Internet]. 2017. Available: https://www.ecfs.eu/sites/default/files/general-content-images/working-g...
-
- Kerem BS, Zielenski J, Markiewicz D, et al. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A. 1990;87:8447-8451.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
